Shares of InfuSystems Holdings, Inc. (INFU) have gained 1.8% over the past four weeks to close the last trading session at $10, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 40%.The average comprises five short-term price targets ranging from a low of $12.00 to a high of $15.00, with a standard deviation of $1.41. While the lowest estimate i ...

While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors use fundamental analysis and ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2025 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from _____ to _____ Commission File Number: 001-35020 INFUSYSTEM HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 20-33414 ...

InfuSystem Holdings (NYSEAM:INFU) Q3 2025 Earnings Call November 04, 2025 09:00 AM ET Speaker3Good day and welcome to the InfuSystem Third Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on a touch-tone phone. To withdraw your question, please ...

InfuSystem Holdings (NYSEAM:INFU) Q3 2025 Earnings Call November 04, 2025 09:00 AM ET Speaker0Good day, and welcome to the InfuSystem Third Quarter twenty twenty five Earnings Conference Call. All participants will be in listen only mode. After today's presentation, there will be an opportunity to ask questions. Please note this event is being recorded. I would now like to turn the conference over to Joe Dorme of Wittham Partners.Please go ahead.Speaker1Good morning and thank you for joining us today to rev ...

InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +37.50%. A quarter ago, it was expected that this company would post earnings of $0.03 per share when it actually produced earnings of $0.12, delivering a surprise of +300%.Over the last four quarters, t ...

Nov 4, 2025 6:30 AM Eastern Standard Time InfuSystem Reports Third Quarter 2025 Financial Results Share Record Net Revenues of $36.5 million Representing 3% Growth from the Prior YearNet income of $2.3 million, up 25%Adjusted EBITDA (non-GAAP) of $8.3 million, up 6%Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23%Year-to-Date Net Operating Cash Flow of $17.3 million, up 38%Stock Repurchases totaled $2.2 million during third quarterReaffirms Full-Year 2025 Guidance ROCHESTER HILLS, Mich.--(BUSINESS W ...

Oct 28, 2025 4:30 PM Eastern Daylight Time Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem†or the "Company†), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. The Company will ...

投资策略 - 短期趋势投资是最盈利的策略 但趋势的可持续性难以把握[1] - 成功的交易需确认基本面稳健、盈利预测上调等因素以维持股票动能[2] - 独特的短期交易策略筛选出具有基本面支撑且维持近期上涨趋势的股票[3] 公司价格表现 - 公司在过去12周内股价上涨78.6% 反映投资者看好其潜在上涨空间[4] - 过去四周股价上涨2% 确认当前上涨趋势仍在延续[5] - 公司目前交易价格位于52周高-低区间的89.4% 暗示可能即将突破[5] 公司基本面与评级 - 公司获得Zacks Rank 1（强力买入）评级 位列4000多只股票的前5%[6] - Zacks Rank 1 股票自1988年以来实现年均25%的回报率[7] - 平均经纪商建议评级为1（强力买入） 显示机构对其短期价格表现高度乐观[7] 筛选工具与适用范围 - “近期价格强度”筛选器可帮助识别符合趋势投资条件的其他股票[8] - Zacks提供超过45种预设筛选策略 可根据个人投资风格选择以超越市场[8] - 成功的选股策略需经过历史回测验证其盈利能力[9]

动量投资方法论 - 动量投资核心是追踪股票近期趋势 在上涨趋势中买入高价并期待以更高价卖出[1] - 趋势确立后更可能延续 目标是通过趋势路径实现及时盈利交易[1] - 动量指标选择存在争议 Zacks动量风格评分系统帮助界定动量特征[2] InfuSystems动量表现 - 当前动量风格评分获B级 同时拥有Zacks排名第1级(强力买入)[3][4] - 过去一周股价上涨12.64% 同期医疗产品行业持平[6] - 月度涨幅达84.27% 显著超越行业6.09%的表现[6] - 季度涨幅81.18% 年度涨幅62.1% 分别超越标普500的9.8%和15.8%[7] 交易量分析 - 20日平均交易量为354,055股 量价关系成为重要观察指标[8] - 放量上涨通常为看涨信号 放量下跌则通常为看跌信号[8] 盈利预测修正 - 过去两个月全年盈利预测获1次上调 无下调[10] - 共识预期从0.06美元大幅提升至0.26美元 增幅超过333%[10] - 下财年预测同样获1次上调 期间无任何下调修正[10] 综合评估 - 结合价格动能与盈利预测上调 INFU同时具备强力买入评级和B级动量评分[12] - 评分组合历史显示 评级1-2级且风格评分A/B级的股票在未来一月普遍跑赢市场[4]